[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@tom_the_bomb__ Avatar @tom_the_bomb__ β›πŸ…ΎοΈβ“‚οΈπŸ’£

β›πŸ…ΎοΈβ“‚οΈπŸ’£ posts on X about $azn, $991m, $pfe, unlock the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks finance currencies cryptocurrencies

Social topic influence $azn #132, $991m, $pfe, unlock, $43b, pfe, top1, $dsnky, novartis, $rog

Top assets mentioned AstraZeneca PLC (AZN) Pfizer, Inc. (PFE) Novartis AG (NVS) ROGin AI (ROG) Merck & Co., Inc. (MRK) Eli Lilly and Company (LLY)

Top Social Posts #


Top posts by engagements in the last XX hours

"Boehringer Ingelheim advances ADC portfolio with an Exatecan-based ADC (AMB304) from AimedBio worth up to $991M. AMB304 is a preclinical asset. AimedBio have one asset in Phase X. #AVCT"
X Link @tom_the_bomb__ 2025-10-15T16:48Z 3305 followers, 3738 engagements

"I wonder what BP is saying about #AVCTs preCISION platform Pfizer: Buy once unlock Seagens entire ADC portfolio & finally dose TOP1 payloads without hitting toxicity walls. Turns a $43B Seagen buy into a platform that actually reaches its potential. 1/4 #AVCT $PFE"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3304 followers, 3150 engagements

"AstraZeneca: Integrate preCISION to extend #Enhertus reach significantly improve dosing potential & move TOP1 chemistry into new tumour types. Frees them from dependency on $DSNKY and creates a next-gen deruxtecan. 2/4 #AVCT $AZN #AZN"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 1795 engagements

"@TBSfrench @AndrewDigby3 Not a shit week RH and his investors moved the SP north by fading the shadow of no cash Are you implying theres another placing on the way"
X Link @tom_the_bomb__ 2025-10-17T21:22Z 3305 followers, XX engagements

"@SeanDentBsc @TragedyCalls So which will it be. Partnerships then a buyout makes the most sense (and definitely my preference before 6103 data)"
X Link @tom_the_bomb__ 2025-10-16T11:51Z 3305 followers, XXX engagements

"@JStonker They stuck Novartis at the bottom & Avacta at the top next to AZN. πŸ˜„ #AVCT is an "Unmissable event highlight" alongside Roche $ROG and AstraZeneca #AZN $AZN. @avacta has a LOT of industry eyes on their patented preCISION tech"
X Link @tom_the_bomb__ 2025-09-02T14:08Z 3301 followers, XXX engagements

"@AndrewDigby3 @asininitybeyond Pfizer. Even better. #Fight"
X Link @tom_the_bomb__ 2025-10-14T14:17Z 3301 followers, XXX engagements

"Just added more #AVCT & #MKA to my SIPP. Two companies that I believe will have a great Q4 2025 & more broadly throughout 2026. I added to #GGP last week too. #LetsGo DYOR"
X Link @tom_the_bomb__ 2025-10-09T07:11Z 3302 followers, 5565 engagements

""FAP-Dox and FAP-EXd are only the tip of the preCISION iceberg" Under the surface: "preCISION molecules in stages of preclinical testing and prep work for the clinic. Multiple therapeutic classes (n10)" Likely 11-15+ molecules across multiple therapeutic classes. #AVCT"
X Link @tom_the_bomb__ 2025-10-13T11:36Z 3305 followers, 2510 engagements

"@AndrewDigby3 @asininitybeyond The CSO has worked at AstraZeneca"
X Link @tom_the_bomb__ 2025-10-14T14:34Z 3300 followers, XXX engagements

"@asininitybeyond BIG update/insight from TD (IMO). A ATR or PARP inhibitor sits with the recent comments on an incoming pathway inhibitor deal. Few BP have both of these drug classes apart from AstraZeneca. #AVCT's dual-payload linker would solve AZs biggest limitation = overlapping toxicity"
X Link @tom_the_bomb__ 2025-10-14T14:12Z 3304 followers, 1706 engagements

"@asininitybeyond @Towlie1981 @PJ_Crabb AI's view below. #AVCT"
X Link @tom_the_bomb__ 2025-10-13T08:39Z 3304 followers, 1964 engagements

"Merck: Combine tumour-activated chemo with #Keytruda to deliver unprecedented tumour clearance while preserving immune function. A whole new class: chemo-immunotherapy XXX. 4/4 #AVCT $MRK"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 3690 engagements

"@Jenkoool Huge amounts of money around for preclinical assets. Which is why I keep leaning towards a buyout sooner rather than later. Ample opportunity to sign multiple deals"
X Link @tom_the_bomb__ 2025-10-15T18:38Z 3305 followers, XXX engagements

"Eli Lilly: Leapfrog the ADC incumbents by pairing preCISION-exatecan with our bispecifics radiopharma & IO assets. Precision chemo without the ADC baggage = faster cleaner cheaper. 3/4 #AVCT $LLY"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 2777 engagements